<DOC>
	<DOCNO>NCT00723931</DOCNO>
	<brief_summary>Surveillance conduct digestive department internal medicine university general hospital participant chronic hepatitis C generally treat . The purpose surveillance evaluate postmarketing safety efficacy PegIntron Injection actual condition use examine adverse event , serious adverse event , adverse drug reaction .</brief_summary>
	<brief_title>PegIntron Injection Surveillance Plan ( Study P04123 )</brief_title>
	<detailed_description>The investigator record continuously first patient since day contract number patient contract base Pegintron approval .</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Participants chronic hepatitis C treat peginterferon alfa2b . Signed write contract .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>